AU7490300A - Human inflammatory breast carcinoma xenograft capable of lymphovascular invasionand methods for its use - Google Patents

Human inflammatory breast carcinoma xenograft capable of lymphovascular invasionand methods for its use

Info

Publication number
AU7490300A
AU7490300A AU74903/00A AU7490300A AU7490300A AU 7490300 A AU7490300 A AU 7490300A AU 74903/00 A AU74903/00 A AU 74903/00A AU 7490300 A AU7490300 A AU 7490300A AU 7490300 A AU7490300 A AU 7490300A
Authority
AU
Australia
Prior art keywords
invasionand
lymphovascular
methods
breast carcinoma
inflammatory breast
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU74903/00A
Inventor
Mary L. Alpaugh
Sanford H. Barsky
James S. Tomlinson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California filed Critical University of California
Publication of AU7490300A publication Critical patent/AU7490300A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New breeds of animals
    • A01K67/027—New breeds of vertebrates
    • A01K67/0271—Chimeric animals, e.g. comprising exogenous cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0331—Animal model for proliferative diseases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
AU74903/00A 1999-09-17 2000-09-15 Human inflammatory breast carcinoma xenograft capable of lymphovascular invasionand methods for its use Abandoned AU7490300A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15440899P 1999-09-17 1999-09-17
US60154408 1999-09-17
PCT/US2000/025299 WO2001019967A1 (en) 1999-09-17 2000-09-15 Human inflammatory breast carcinoma xenograft capable of lymphovascular invasion and methods for its use

Publications (1)

Publication Number Publication Date
AU7490300A true AU7490300A (en) 2001-04-17

Family

ID=22551246

Family Applications (1)

Application Number Title Priority Date Filing Date
AU74903/00A Abandoned AU7490300A (en) 1999-09-17 2000-09-15 Human inflammatory breast carcinoma xenograft capable of lymphovascular invasionand methods for its use

Country Status (3)

Country Link
US (1) US6998513B1 (en)
AU (1) AU7490300A (en)
WO (1) WO2001019967A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10134667A1 (en) * 2001-07-20 2003-02-06 Neuroprogen Gmbh Leipzig Process for the production of isolated cell cultures, culture medium for the cultivation of cell cultures and cell culture
EP2529238A4 (en) 2010-01-28 2014-10-08 The Regents Of The University Of Michigan Hanging drop devices, systems and/or methods
CA3067602A1 (en) * 2017-06-29 2019-01-03 Juno Therapeutics, Inc. Mouse model for assessing toxicities associated with immunotherapies
CN111034680A (en) * 2019-12-31 2020-04-21 南京普恩瑞生物科技有限公司 Method for establishing mouse orthotopic transplantation model of triple-negative breast cancer living tumor tissue

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5508188A (en) 1994-01-21 1996-04-16 The Regents Of The University Of California Method of growing cells in a mammal

Also Published As

Publication number Publication date
US6998513B1 (en) 2006-02-14
WO2001019967A1 (en) 2001-03-22

Similar Documents

Publication Publication Date Title
AU2002226069A1 (en) Compositions comprising temozolomide and thalidomide and methods for the treatment of cancer
HRP20030463A2 (en) Heterocyclic ether substited imidazoquinolines
AU6147401A (en) Compositions and methods for the treatment of cancer
AU2003200722A1 (en) Compositions and methods for the treatment of tumor
AU2003200731A1 (en) Compositions and methods for the treatment of tumor
AU2003200740A1 (en) Compositions and methods for the treatment of tumor
AU2495200A (en) Compositions and methods for the treatment of tumor
AU2001260847A1 (en) Compositions isolated from skin cells and methods for their use
IL151890A0 (en) Hydroxyphenyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
AU3391200A (en) Compositions and methods for breast cancer therapy and diagnosis
HUP0300848A3 (en) A composition comprising camptothecin and a pyrimidine derivative for the treatment of cancer
AU2980900A (en) Methods for human allografting
AU5493400A (en) Absorbent airlaid structure
AU2001275707A1 (en) Use of panaxatriol for stimulation angiogenesis
IL151765A0 (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
IL151891A0 (en) Quinolinyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
AU5638400A (en) Compositions and methods for the therapy and diagnosis of breast cancer
AU2001284763A1 (en) Preparation of risperidone
AU1953701A (en) Methods and compositions for treatment of inflammatory disease
AU7490300A (en) Human inflammatory breast carcinoma xenograft capable of lymphovascular invasionand methods for its use
IL151523A0 (en) Use of avocado-soybean unsaponifiable preparations
HK1048633A1 (en) Preparation of 3-substituted-4-arylquinolin-2-one derivatives
AU2001286341A1 (en) Therapeutic bio-energy unit
AU4859500A (en) Droop-free quasi-continuous reconstruction filter interface
AU2000243264A1 (en) Human nim1 kinase

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase